title: Carbonic anhydrase inhibitors, interaction of boron derivatives with isozymes I and II: a new binding site for hydrophobic inhibitors at the entrance of the active site as shown by docking studies.
abstract: The interaction of human carbonic anhydrase (hCA) isozymes I and II with boron derivatives was investigated by kinetic and spectroscopic studies. These derivatives, tested as new inhibitors of carbonic anhydrase, are sulfonamide and non-sulfonamide boron derivatives and some of them proved to be moderately efficient inhibitors of hCA I and hCA II, their activities being comparable to those of the unsubstituted sulfonamides, the classical inhibitors of these zinc enzymes. Ph(2) BOH, one of the compounds with the highest affinity for hCA II in the present study, has been docked within the active site. After minimisation it was found situated at 7.9 A from zinc, within the hydrophobic half of the active site, in Van der Waals contacts with the amino acid residues: Val 121, Phe 130, Val 135, Leu 141, Val 143, Val 207 and Pro 201. This is the first time that a CA inhibitor has been found to bind at the edge of the active site cavity, similarly to the CA activator histamine, which binds on the hydrophilic half. This finding may be of importance also for the design of novel types of inhibitors with increased affinity for the different CA isozymes.
authors.affiliation: Université Paul Sabatier, Laboratoire d'Hétérochimie Fondamentale et Appliquée, UMR 5069 du CNRS, 118 route de Narbonne, 31062 Toulouse Cedex, France.
authors.forename: C
authors.initials: C
authors.lastname: Chazalette
authors.forename: M
authors.initials: M
authors.lastname: Riviere-Baudet
authors.forename: A
authors.initials: A
authors.lastname: Scozzafava
authors.forename: F
authors.initials: F
authors.lastname: Abbate
authors.forename: Z
authors.initials: Z
authors.lastname: Ben Maarouf
authors.forename: C T
authors.initials: CT
authors.lastname: Supuran
mesh_terms: D001665:Binding Sites; D001896:Boron Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002257:Carbonic Anhydrase Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002256:Carbonic Anhydrases / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D007202:Indicators and Reagents; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000737:chemistry; D007700:Kinetics; D008958:Models, Molecular; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D013329:Structure-Activity Relationship
chemical_list: D001896:Boron Compounds; D002257:Carbonic Anhydrase Inhibitors; D007202:Indicators and Reagents; D007527:Isoenzymes; D002256:Carbonic Anhydrases